Clinical Trial

A Single Ascending Dose of HRS-4029 in Healthy Subjects

Name: A Single Ascending Dose of HRS-4029 in Healthy Subjects — clinical trial record (NCT06905314)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated April 1, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.

Summary

The study is being conducted to evaluate the safety, tolerability and pharmacokinetics of HRS-4029 following a single intravenous dose administration in healthy subjects.

Trial Details

NCT Number	NCT06905314
Lead Sponsor	Beijing Suncadia Pharmaceuticals Co., Ltd
Conditions	Acute Ischemic Stroke
Enrollment	55 participants
Start Date	2025-04
Primary Completion	2025-10 (estimated)
Study Completion	2025-12 (estimated)
Updated on ClinicalTrials.gov	2025-04-01